The evolution and development of insomnia pharmacotherapies.
作者信息
Neubauer David N
机构信息
Sleep Disorders Center Johns Hopkins University School of Medicine, Baltimore, MD, USA.
出版信息
J Clin Sleep Med. 2007 Aug 15;3(5 Suppl):S11-5.
Abstract
摘要
相似文献
1
The evolution and development of insomnia pharmacotherapies.失眠药物治疗的演变与发展
J Clin Sleep Med. 2007 Aug 15;3(5 Suppl):S11-5.
2
Treatment of insomnia.失眠的治疗。
Treat Guidel Med Lett. 2006 Feb;4(42):5-10.
3
[Hypnotics in pharmaceutical sales?].[药品销售中的催眠药？]
Med Monatsschr Pharm. 1994 Aug;17(8):251.
4
Best bets for managing insomnia: drug therapy, behavioral interventions.治疗失眠的最佳方法：药物治疗、行为干预。
Rep Med Guidel Outcomes Res. 2001 Apr 5;12(7):10, 12.
5
[Pharmacological treatment of insomnia].[失眠的药物治疗]
Psychiatr Pol. 2006 May-Jun;40(3):563-77.
6
[Prescriptions for insomnia].[失眠症的处方]
MMW Fortschr Med. 2005 Nov 24;147(47):11.
7
The beneficial and adverse effects of hypnotics.催眠药的有益和不良影响。
J Clin Psychiatry. 1991 Jul;52 Suppl:16-23.
8
Drugs for insomnia.治疗失眠的药物。
Treat Guidel Med Lett. 2009 Mar;7(79):23-6.
9
Insomnia in the elderly: cause, approach, and treatment.老年人失眠：病因、处理方法及治疗
Am J Med. 2006 Jun;119(6):463-9. doi: 10.1016/j.amjmed.2005.10.051.
10
Insomnia pharmacology.失眠症药物治疗学。
Med Clin North Am. 2010 May;94(3):563-80. doi: 10.1016/j.mcna.2010.02.012.
引用本文的文献
1
Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study.雷美替胺，一种用于治疗失眠症的双重食欲素受体拮抗剂（DORA）：一项贝叶斯、适应性、随机、双盲、安慰剂对照研究的结果。
J Clin Sleep Med. 2017 Nov 15;13(11):1289-1299. doi: 10.5664/jcsm.6800.
2
Characteristics and Trends in Hypnotics Consumption in the Largest Health Care System in Israel.以色列最大医疗保健系统中催眠药物消费的特征与趋势
Sleep Disord. 2016;2016:8032528. doi: 10.1155/2016/8032528. Epub 2016 Aug 31.
3
Learning and Memory Deficits in Male Adult Mice Treated with a Benzodiazepine Sleep-Inducing Drug during the Juvenile Period.幼年时期接受苯二氮䓬类助眠药物治疗的成年雄性小鼠的学习与记忆缺陷
Front Neurosci. 2016 Jul 20;10:339. doi: 10.3389/fnins.2016.00339. eCollection 2016.
4
Trial of Zolpidem, Eszopiclone, and Other GABA Agonists in a Patient with Progressive Supranuclear Palsy.唑吡坦、艾司佐匹克隆及其他GABA激动剂治疗进行性核上性麻痹患者的试验
Case Rep Med. 2014;2014:107064. doi: 10.1155/2014/107064. Epub 2014 Sep 16.
5
Survivorship: sleep disorders, version 1.2014.生存状况：睡眠障碍，版本 1.2014。
J Natl Compr Canc Netw. 2014 May;12(5):630-42. doi: 10.6004/jnccn.2014.0067.
6
Efficacy of vestipitant, a neurokinin-1 receptor antagonist, in primary insomnia.神经激肽-1受体拮抗剂阿瑞匹坦治疗原发性失眠的疗效
Sleep. 2013 Dec 1;36(12):1823-30. doi: 10.5665/sleep.3208.
7
[Medicine consumption in the adult population: Influence of self-medication].[成年人群体中的药物消费：自我药疗的影响]
Aten Primaria. 2013 Dec;45(10):528-35. doi: 10.1016/j.aprim.2013.05.006. Epub 2013 Sep 12.
8
Middle-of-the-night hypnotic use in a large national health plan.在一项大型国家健康计划中，半夜使用催眠。
J Clin Sleep Med. 2013 Jul 15;9(7):661-8. doi: 10.5664/jcsm.2832.
9
Effects of eszopiclone on safety, subjective measures of efficacy, and quality of life in elderly and nonelderly Japanese patients with chronic insomnia, both with and without comorbid psychiatric disorders: a 24-week, randomized, double-blind study.在伴有和不伴有合并精神疾病的老年和非老年慢性失眠日本患者中，eszopiclone 对安全性、主观疗效测量和生活质量的影响：一项 24 周、随机、双盲研究。
Ann Gen Psychiatry. 2012 Jun 25;11(1):15. doi: 10.1186/1744-859X-11-15.
10
Prevalence and factors associated with off-label antidepressant prescriptions for insomnia.失眠症非标签抗抑郁药处方的患病率及相关因素。
Drug Healthc Patient Saf. 2011;3:27-36. doi: 10.2147/DHPS.S21079. Epub 2011 Jul 8.
本文引用的文献
1
The human circadian system in normal and disordered sleep.正常睡眠和睡眠障碍中的人体昼夜节律系统。
J Clin Psychiatry. 2005;66 Suppl 9:3-9; quiz 42-3.
2
Ramelteon.雷美替胺
CNS Drugs. 2005;19(12):1057-65; discussion 1066-7. doi: 10.2165/00023210-200519120-00007.
3
National Institutes of Health State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults, June 13-15, 2005.美国国立卫生研究院关于成人慢性失眠的表现与管理的科学现状会议声明，2005年6月13日至15日
Sleep. 2005 Sep;28(9):1049-57. doi: 10.1093/sleep/28.9.1049.
4
Long-term use of sedative hypnotics in older patients with insomnia.老年失眠患者长期使用镇静催眠药。
Sleep Med. 2005 Mar;6(2):107-13. doi: 10.1016/j.sleep.2004.10.015. Epub 2005 Jan 26.
5
Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist.雷美替胺（TAK-375）的神经化学特性，一种选择性MT1/MT2受体激动剂。
Neuropharmacology. 2005 Feb;48(2):301-10. doi: 10.1016/j.neuropharm.2004.09.007.
6
Drugs used to treat insomnia in 2002: regulatory-based rather than evidence-based medicine.2002年用于治疗失眠的药物：基于监管而非循证医学。
Sleep. 2004 Dec 15;27(8):1441-2. doi: 10.1093/sleep/27.8.1441.
7
Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia.每晚服用艾司佐匹克隆6个月的持续疗效：一项针对成年慢性失眠患者的随机、双盲、安慰剂对照研究的结果
Sleep. 2003 Nov 1;26(7):793-9. doi: 10.1093/sleep/26.7.793.
8
Tolerance to daytime sedative effects of H1 antihistamines.对H1抗组胺药日间镇静作用的耐受性。
J Clin Psychopharmacol. 2002 Oct;22(5):511-5. doi: 10.1097/00004714-200210000-00012.
9
Subunit composition, distribution and function of GABA(A) receptor subtypes.γ-氨基丁酸A（GABA(A)）受体亚型的亚基组成、分布及功能
Curr Top Med Chem. 2002 Aug;2(8):795-816. doi: 10.2174/1568026023393507.
10
GABA mechanisms and sleep.γ-氨基丁酸机制与睡眠。
Neuroscience. 2002;111(2):231-9. doi: 10.1016/s0306-4522(02)00034-9.
Zotero 插件